.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Baxter
Farmers Insurance
Citi
Colorcon
Deloitte
Novartis
Mallinckrodt
Covington
Fuji

Generated: September 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018594

« Back to Dashboard
NDA 018594 describes TOPICORT, which is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TOPICORT profile page.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for NDA: 018594

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 018594

Suppliers and Packaging for NDA: 018594

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOPICORT
desoximetasone
OINTMENT;TOPICAL 018594 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-1352 51672-1352-1 1 TUBE in 1 CARTON (51672-1352-1) > 15 g in 1 TUBE
TOPICORT
desoximetasone
OINTMENT;TOPICAL 018594 NDA Taro Pharmaceuticals U.S.A., Inc. 51672-1352 51672-1352-2 1 TUBE in 1 CARTON (51672-1352-2) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Jan 17, 1985TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
US Army
Colorcon
Citi
Healthtrust
Julphar
Accenture
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot